Climb Bio, Inc. is a biotechnology firm headquartered in Wilmington, Delaware, dedicated to innovating and advancing therapies for autoimmune-driven inflammatory diseases. With a robust pipeline of drug candidates, Climb Bio leverages cutting-edge science to address unmet medical needs in this critical sector. The company's commitment to research and development positions it as a key player in the biotechnology landscape, focusing on improving patient outcomes through targeted and effective treatments.
Click "Analyze" to generate stock analysis
CLYM Price Trend and Signals
CLYM Financials
2025-10-20Somewhat Bullishprice_signal
Monthly high detected.
2025-10-20Bullishprice_signal
Large price change detected: 20.21%.
2025-10-17Bullishmacd_signal
Golden cross below zero detected.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.